Therapeutic Advances in Drug Safety

Papers
(The H4-Index of Therapeutic Advances in Drug Safety is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Development and psychometric assessment of self-reported patient medication safety scale (SR-PMSS)38
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study35
Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada28
Enhancing pharmacovigilance for robust drug safety monitoring: addressing underreporting and collaborative solutions26
Acceptability of a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice: a mixed methods study18
Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community16
Medication errors by caregivers in the homes of children discharged from a pediatric department in Ghana15
Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database15
Corrigendum13
A critical opinion-based review of hospital pharmacy compounding with respect to the risk of leachable substances due to the off-label use of plastic primary packaging13
Semaglutide: a gendered phenomenon—women’s increased vulnerability to adverse drug reactions in the global weight loss trend13
Incidence of antibody–drug conjugate-related hepatotoxicity in breast cancer: a systematic review and meta-analysis12
Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey12
0.096863031387329